Invenux is a privately held clinical stage biopharmaceutical company whose focus is the research and development of drugs for orphan diseases. The first drug candidate is SCD-101 for the treatment of sickle cell disease. The primary goal of Invenux is to commercialize orphan drugs like SCD-101 through corporate partnerships that result in upfront, milestone, and…
iC42 Clinical Research & Development supports pre-clinical and clinical drug development programs, assists with bringing drug candidates into clinical development, and serves as a resource for the biotech and pharmaceutical industry. Major focus areas include the evaluation of pharmacokinetics, drug metabolism, and the development of clinical management tools for pediatric patients. iC42 Clinical Research &…
Website Exxel Pharma is a development stage company that combines world-class leadership, expert technological know-how, and experience from the pharmaceutical industry to develop medicines for significant unmet medical needs. Exxel Pharma is focused on the development of innovative, small-molecule therapeutics for the treatment of chronic cough, pain, and CNS disorders, and aims to become the…
Website Endourage is developing hemp-derived, safe therapies for clinical use that target specific indications. Decisions are informed by licensed clinicians with board certifications and advisory board roles spanning medicine, pharmacology, and agronomy. Endourage formulations are developed in collaboration with practicing clinicians and researchers.